Copyright in the material you requested is held by American College Of Physicians
(unless otherwise noted). This email ability is provided as a courtesy, and by using
it you agree that that you are requesting the material solely for personal, non-commercial
use, and that it is subject to ACP's Conditions of Use.
The information provided in order to email this topic will not be used to send unsolicited
email, nor will it be furnished to third parties. Please refer to
American College Of Physicians'sPrivacy
Policy for further information.

Frequency of Birth Control Services with Prescriptions for Unsafe Drugs During PregnancyFREE

The summary below is from the full report titled “Documentation of Contraception and Pregnancy When Prescribing Potentially Teratogenic Medications for Reproductive-Age Women.” It is in the 18 September 2007 issue of Annals of Internal Medicine (volume 147, pages 370-376). The authors are E.B. Schwarz, D.A. Postlethwaite, Y.Y. Hung, and M.A. Armstrong.

What is the problem and what is known about it so far?

Some drugs can cause birth defects and other problems if a woman takes them while pregnant. The U.S. Food and Drug Administration classifies drugs according to safety during pregnancy. Drugs in classes A and B are safe, whereas drugs in classes D and X are potentially unsafe. Women who receive prescriptions for class D and X drugs should also receive counseling about birth control if they could become pregnant (that is, if they are sexually active with men, have not yet gone through menopause, and have not had a hysterectomy or had their tubes tied). Appropriate birth control services include counseling to avoid sexual activity until after they have stopped taking the drug, prescription of birth control drugs or devices, or regular use of condoms or other nonmedical forms of birth control.

Why did the researchers do this particular study?

The researchers wanted to find out how often women who filled prescriptions for drugs that can be unsafe during pregnancy also received birth control services.

Who was studied?

The researchers studied all prescriptions for class A, B, D, or X drugs filled in 2001 by women age 15 to 44 years and who belonged to a large managed care plan in California.

How was the study done?

The researchers examined health plan data (not medical charts) to look for drug prescriptions and for codes for birth control counseling, birth control drugs, or sterilization procedures (hysterectomy or having had tubes tied). They compared how often women taking safe drugs (classes A and B) and unsafe drugs (classes D and X) received contraceptive services or had a positive pregnancy test. They also looked for differences depending on the type of potentially unsafe drug prescribed.

What did the researchers find?

Women who filled prescriptions for class D or X drugs were no more likely than women who filled prescriptions for safer, class A or B drugs to have received birth control services. One percent of women taking class D and X drugs had a positive pregnancy test within 3 months of the drug prescription compared with 1.4% of women taking class A or B drugs. The researchers did not look at the outcomes of these pregnancies. Women taking the acne drug isotretinoin received birth control services more frequently than women taking any other types of unsafe drugs, whereas women taking cholesterol drugs (statins) received birth control services less frequently.

What were the limitations of the study?

Because the researchers did not examine the medical charts, they could not determine whether women were sexually active or using condoms or other forms of contraception that would not generate a billing code. For this reason, the study might overestimate the frequency of inadequate birth control. It is unknown whether the findings in this specific managed care plan apply to other health care settings.

What are the implications of the study?

Women who could become pregnant and their doctors must remember the importance of birth control when medications that may be unsafe during pregnancy are used.

Comments

Please read the other comments before posting. Contributors must reveal any conflict
of interest.
Comments are moderated and will appear on the site at the discretion of The American
College of Physicians editorial staff. Please be sure your email address is
updated in your account, otherwise the American College of Physicians will not be
able to contact you about your comment.

* = Required Field

Comment Author(s)* (if multiple authors,
separate names by comma)

Example: John Doe

Affiliation & Institution*

Disclosure of Any Conflicts of Interest*
(applies to the past 5 years and foreseeable future) Indicate any potential conflicts
of interest of each author below, including specific financial interests and relationships
and affiliations relevant to the subject matter or materials discussed in the manuscript
(eg, employment/affiliation, grants or funding, consultancies, honoraria, speakers
bureau, stock ownership or options, expert testimony, royalties, donation of medical
equipment, or patents filed, received, or pending). If all authors have none, check
"No potential conflicts or relevant financial interests" in the box below. Please
also indicate any funding received in support of this work. The information will
be posted with your response.

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College
of Physicians (ACP). All text, graphics, trademarks, and other intellectual property
incorporated into the slide sets remain the sole and exclusive property of the ACP.
The slide sets may be used only by the person who downloads or purchases them and
only for the purpose of presenting them during not-for-profit educational activities.
Users may incorporate the entire slide set or selected individual slides into their
own teaching presentations but may not alter the content of the slides in any way
or remove the ACP copyright notice. Users may make print copies for use as hand-outs
for the audience the user is personally addressing but may not otherwise reproduce
or distribute the slides by any means or media, including but not limited to sending
them as e-mail attachments, posting them on Internet or Intranet sites, publishing
them in meeting proceedings, or making them available for sale or distribution in
any unauthorized form, without the express written permission of the ACP. Unauthorized
use of the In the Clinic slide sets will constitute copyright infringement.